0.15Open0.15Pre Close0 Volume110 Open Interest40.00Strike Price0.00Turnover230.00%IV213.67%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier24DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.0563Delta0.0147Gamma85.33Leverage Ratio-0.0171Theta0.0004Rho4.81Eff Leverage0.0038Vega
Sage Therapeutics Stock Discussion
oooooo
Gapping up
$Salesforce(CRM.US)$ jumped 6.2% following its earnings beat after the bell Wednesday. Adjusted earnings per share came in at $2.12 for the second quarter, versus the consensus estimate of $1.90, per Refinitiv. Revenue was $8.60 billion, topping the $8.53 expected. Goldman Sachs subsequently hiked its price target by $15 to $340 a share, suggestions 58% upside.
$UBS Group(UBS.US)$ popp...
follow for daily watchlist 🚀
Great entry point. As long as it is approved and on the market, it will be open for off-label use for MDD if someone really wants it.
However MDD 一般抑郁症 is not approved. Although they are not serious enough for MDD. MDD means huge money. And people with MDD typically take pills for years. Guess what, wall street and elites, they know mental health better than you
Now no huge money but just big mon...
No comment yet